Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 23 studies | 26% ± 10% | |
macrophage | 21 studies | 26% ± 9% | |
fibroblast | 19 studies | 24% ± 7% | |
classical monocyte | 12 studies | 25% ± 11% | |
microglial cell | 11 studies | 28% ± 11% | |
adipocyte | 9 studies | 25% ± 7% | |
alveolar macrophage | 8 studies | 48% ± 18% | |
monocyte | 8 studies | 35% ± 17% | |
myeloid cell | 8 studies | 32% ± 6% | |
astrocyte | 8 studies | 27% ± 10% | |
non-classical monocyte | 7 studies | 29% ± 12% | |
B cell | 7 studies | 22% ± 4% | |
glutamatergic neuron | 7 studies | 42% ± 24% | |
oligodendrocyte | 7 studies | 27% ± 8% | |
epithelial cell | 6 studies | 33% ± 19% | |
dendritic cell | 6 studies | 27% ± 11% | |
GABAergic neuron | 6 studies | 38% ± 19% | |
mononuclear phagocyte | 5 studies | 25% ± 7% | |
basal cell | 5 studies | 31% ± 15% | |
endothelial cell of artery | 5 studies | 17% ± 2% | |
type II pneumocyte | 5 studies | 20% ± 4% | |
pericyte | 5 studies | 22% ± 4% | |
smooth muscle cell | 5 studies | 20% ± 4% | |
interneuron | 5 studies | 34% ± 21% | |
capillary endothelial cell | 4 studies | 18% ± 1% | |
neuron | 4 studies | 28% ± 10% | |
ciliated cell | 4 studies | 29% ± 5% | |
lymphocyte | 4 studies | 24% ± 4% | |
endothelial cell of vascular tree | 4 studies | 24% ± 13% | |
endothelial cell of lymphatic vessel | 4 studies | 22% ± 6% | |
oligodendrocyte precursor cell | 4 studies | 28% ± 9% | |
type I pneumocyte | 4 studies | 23% ± 5% | |
conventional dendritic cell | 3 studies | 25% ± 7% | |
glial cell | 3 studies | 21% ± 5% | |
plasma cell | 3 studies | 22% ± 5% | |
retinal cone cell | 3 studies | 18% ± 1% | |
cardiac muscle cell | 3 studies | 16% ± 2% | |
mesothelial cell | 3 studies | 24% ± 2% | |
natural killer cell | 3 studies | 18% ± 1% | |
adventitial cell | 3 studies | 21% ± 6% | |
T cell | 3 studies | 20% ± 3% | |
club cell | 3 studies | 22% ± 5% | |
secretory cell | 3 studies | 23% ± 8% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 1104.24 | 1443 / 1445 | 100% | 15.26 | 183 / 183 |
ovary | 100% | 1528.74 | 180 / 180 | 100% | 11.04 | 429 / 430 |
lung | 100% | 2418.21 | 578 / 578 | 100% | 16.17 | 1152 / 1155 |
intestine | 100% | 900.93 | 966 / 966 | 99% | 6.85 | 521 / 527 |
breast | 100% | 1509.14 | 459 / 459 | 98% | 11.80 | 1094 / 1118 |
stomach | 99% | 631.80 | 355 / 359 | 99% | 7.06 | 282 / 286 |
brain | 97% | 867.31 | 2570 / 2642 | 99% | 12.80 | 700 / 705 |
bladder | 100% | 910.24 | 21 / 21 | 96% | 10.33 | 485 / 504 |
uterus | 100% | 1008.43 | 170 / 170 | 96% | 11.28 | 439 / 459 |
skin | 100% | 1924.44 | 1809 / 1809 | 95% | 10.09 | 448 / 472 |
thymus | 100% | 1126.49 | 652 / 653 | 95% | 7.09 | 572 / 605 |
prostate | 100% | 733.49 | 244 / 245 | 92% | 5.15 | 460 / 502 |
pancreas | 94% | 447.27 | 308 / 328 | 97% | 8.10 | 172 / 178 |
kidney | 97% | 636.36 | 86 / 89 | 93% | 7.76 | 839 / 901 |
adrenal gland | 100% | 942.91 | 258 / 258 | 82% | 3.89 | 188 / 230 |
liver | 68% | 252.43 | 154 / 226 | 50% | 2.38 | 205 / 406 |
adipose | 100% | 1614.32 | 1204 / 1204 | 0% | 0 | 0 / 0 |
spleen | 100% | 1093.51 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 2.24 | 1 / 1 |
blood vessel | 100% | 1123.06 | 1333 / 1335 | 0% | 0 | 0 / 0 |
muscle | 99% | 699.97 | 792 / 803 | 0% | 0 | 0 / 0 |
heart | 95% | 764.73 | 815 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 93% | 11.15 | 42 / 45 |
peripheral blood | 90% | 1208.30 | 839 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 70% | 3.24 | 56 / 80 |
lymph node | 0% | 0 | 0 / 0 | 62% | 4.67 | 18 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0007220 | Biological process | Notch receptor processing |
GO_0048870 | Biological process | cell motility |
GO_0032722 | Biological process | positive regulation of chemokine production |
GO_1903265 | Biological process | positive regulation of tumor necrosis factor-mediated signaling pathway |
GO_0033627 | Biological process | cell adhesion mediated by integrin |
GO_0007219 | Biological process | Notch signaling pathway |
GO_0030512 | Biological process | negative regulation of transforming growth factor beta receptor signaling pathway |
GO_0045741 | Biological process | positive regulation of epidermal growth factor-activated receptor activity |
GO_0030307 | Biological process | positive regulation of cell growth |
GO_0043536 | Biological process | positive regulation of blood vessel endothelial cell migration |
GO_0002467 | Biological process | germinal center formation |
GO_0071403 | Biological process | cellular response to high density lipoprotein particle stimulus |
GO_0010820 | Biological process | positive regulation of T cell chemotaxis |
GO_0016485 | Biological process | protein processing |
GO_0045737 | Biological process | positive regulation of cyclin-dependent protein serine/threonine kinase activity |
GO_1905564 | Biological process | positive regulation of vascular endothelial cell proliferation |
GO_0007155 | Biological process | cell adhesion |
GO_0023061 | Biological process | signal release |
GO_0048536 | Biological process | spleen development |
GO_1900087 | Biological process | positive regulation of G1/S transition of mitotic cell cycle |
GO_0033077 | Biological process | T cell differentiation in thymus |
GO_0071679 | Biological process | commissural neuron axon guidance |
GO_0002446 | Biological process | neutrophil mediated immunity |
GO_0045742 | Biological process | positive regulation of epidermal growth factor receptor signaling pathway |
GO_0050830 | Biological process | defense response to Gram-positive bacterium |
GO_0030335 | Biological process | positive regulation of cell migration |
GO_0033025 | Biological process | regulation of mast cell apoptotic process |
GO_0001666 | Biological process | response to hypoxia |
GO_0006508 | Biological process | proteolysis |
GO_0008284 | Biological process | positive regulation of cell population proliferation |
GO_0009410 | Biological process | response to xenobiotic stimulus |
GO_0035313 | Biological process | wound healing, spreading of epidermal cells |
GO_0042987 | Biological process | amyloid precursor protein catabolic process |
GO_0032760 | Biological process | positive regulation of tumor necrosis factor production |
GO_0002690 | Biological process | positive regulation of leukocyte chemotaxis |
GO_0030183 | Biological process | B cell differentiation |
GO_0032496 | Biological process | response to lipopolysaccharide |
GO_0006509 | Biological process | membrane protein ectodomain proteolysis |
GO_0120163 | Biological process | negative regulation of cold-induced thermogenesis |
GO_0032587 | Cellular component | ruffle membrane |
GO_0016324 | Cellular component | apical plasma membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0045121 | Cellular component | membrane raft |
GO_0016020 | Cellular component | membrane |
GO_0005925 | Cellular component | focal adhesion |
GO_0005911 | Cellular component | cell-cell junction |
GO_0009986 | Cellular component | cell surface |
GO_0000139 | Cellular component | Golgi membrane |
GO_0015629 | Cellular component | actin cytoskeleton |
GO_0005788 | Cellular component | endoplasmic reticulum lumen |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0008233 | Molecular function | peptidase activity |
GO_0004175 | Molecular function | endopeptidase activity |
GO_1902945 | Molecular function | metalloendopeptidase activity involved in amyloid precursor protein catabolic process |
GO_0043120 | Molecular function | tumor necrosis factor binding |
GO_0008237 | Molecular function | metallopeptidase activity |
GO_0005112 | Molecular function | Notch binding |
GO_0019955 | Molecular function | cytokine binding |
GO_0005178 | Molecular function | integrin binding |
GO_0030165 | Molecular function | PDZ domain binding |
GO_0005138 | Molecular function | interleukin-6 receptor binding |
GO_0046872 | Molecular function | metal ion binding |
GO_0004222 | Molecular function | metalloendopeptidase activity |
GO_0005515 | Molecular function | protein binding |
GO_0017124 | Molecular function | SH3 domain binding |
Gene name | ADAM17 |
Protein name | ADAM metallopeptidase domain 17 ADAM metallopeptidase domain 17 (ADAM metallopeptidase domain 18) ADAM metallopeptidase domain 17 (ADAM17 protein) ADAM17 protein Uncharacterized protein ADAM17 Disintegrin and metalloproteinase domain-containing protein 17 (ADAM 17) (EC 3.4.24.86) (Snake venom-like protease) (TNF-alpha convertase) (TNF-alpha-converting enzyme) (CD antigen CD156b) |
Synonyms | hCG_23065 ADAM18 CSVP TACE |
Description | FUNCTION: Cleaves the membrane-bound precursor of TNF-alpha to its mature soluble form . Responsible for the proteolytical release of soluble JAM3 from endothelial cells surface . Responsible for the proteolytic release of several other cell-surface proteins, including p75 TNF-receptor, interleukin 1 receptor type II, p55 TNF-receptor, transforming growth factor-alpha, L-selectin, growth hormone receptor, MUC1 and the amyloid precursor protein . Acts as an activator of Notch pathway by mediating cleavage of Notch, generating the membrane-associated intermediate fragment called Notch extracellular truncation (NEXT) . Plays a role in the proteolytic processing of ACE2 . Plays a role in hemostasis through shedding of GP1BA, the platelet glycoprotein Ib alpha chain (By similarity). Mediates the proteolytic cleavage of LAG3, leading to release the secreted form of LAG3 (By similarity). Mediates the proteolytic cleavage of IL6R, leading to the release of secreted form of IL6R . Mediates the proteolytic cleavage and shedding of FCGR3A upon NK cell stimulation, a mechanism that allows for increased NK cell motility and detachment from opsonized target cells. . |
Accessions | ENST00000699318.1 ENST00000699324.1 ENST00000648002.1 A0A3B3ITB5 ENST00000650116.1 A0A8V8TN27 A0A8V8TPV7 A0A8V8TNK7 ENST00000649227.1 A8K1B4 ENST00000310823.8 [P78536-1] ENST00000699321.1 ENST00000699317.1 ENST00000647610.1 A0A3B3IST4 ENST00000699316.1 ENST00000647979.1 ENST00000618923.2 A0A3B3ISQ1 Q53S40 A6H8L4 A0A8V8TPG8 P78536 A0A3B3ITW9 Q6P5T8 Q53RF5 ENST00000647622.1 ENST00000699325.1 Q53RS1 A0A8V8TNK2 B2RNB2 |